SEC Form 4 reporting owner

Gollob Jared

Gollob Jared has filed 16 Form 4 transactions reported between December 8, 2025 and March 4, 2026, as Chief Medical Officer of Kymera Therapeutics, Inc..

Name as filed: Gollob Jared

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$5.3M

13 lines

Companies

with Form 4 filings

Latest transaction

Mar 4, 2026

transaction date

Roles and reported holdings

KYMRKymera Therapeutics, Inc.
Dec 8, 2025 – Mar 4, 2026
Chief Medical Officer
Held directly117,134 sh as of Mar 4, 2026 · Form 4
24 months: $5.3M sold

Transaction history

All 16 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Mar 4, 2026	KYMRChief Medical Officer	Open-market saleCode S · directAlso reported by Jacobs Bruce N.	447	$86.62	$39K@ $86.62	117,134	Form 4
Mar 4, 2026	KYMRChief Medical Officer	Open-market saleCode S · directAlso reported by Jacobs Bruce N.	1,437	$85.78	$123K@ $85.78	117,581	Form 4
Mar 4, 2026	KYMRChief Medical Officer	Open-market saleCode S · directAlso reported by Jacobs Bruce N.	2,519	$85.04	$214K@ $85.04	119,018	Form 4
Mar 4, 2026	KYMRChief Medical Officer	Open-market saleCode S · directAlso reported by Jacobs Bruce N.	492	$84.00	$41K@ $84.00	121,537	Form 4
Mar 2, 2026	KYMRChief Medical Officer	Grant or awardCode A · direct	35,300	—	—	35,300	Form 4
Mar 2, 2026	KYMRChief Medical Officer	Open-market saleCode S · direct	3,048	$89.66	$273K@ $89.66	122,029	Form 4
Mar 2, 2026	KYMRChief Medical Officer	Open-market saleCode S · direct	1,055	$88.50	$93K@ $88.50	125,077	Form 4
Mar 2, 2026	KYMRChief Medical Officer	Open-market saleCode S · direct	1,510	$87.75	$133K@ $87.75	126,132	Form 4
Mar 2, 2026	KYMRChief Medical Officer	Grant or awardCode A · direct	17,650	—	—	127,642	Form 4
Dec 8, 2025	KYMRChief Medical Officer	Open-market saleCode S · direct	1,400	$92.19	$129K@ $92.19	109,992	Form 4
Dec 8, 2025	KYMRChief Medical Officer	Open-market saleCode S · direct	3,300	$91.46	$302K@ $91.46	111,392	Form 4
Dec 8, 2025	KYMRChief Medical Officer	Open-market saleCode S · direct	8,562	$90.12	$772K@ $90.12	114,692	Form 4
Dec 8, 2025	KYMRChief Medical Officer	Open-market saleCode S · direct	3,929	$89.43	$351K@ $89.43	123,254	Form 4
Dec 8, 2025	KYMRChief Medical Officer	Open-market saleCode S · direct	18,357	$88.02	$1.6M@ $88.02	127,183	Form 4
Dec 8, 2025	KYMRChief Medical Officer	Open-market saleCode S · direct	13,759	$87.37	$1.2M@ $87.37	145,540	Form 4
Dec 8, 2025	KYMRChief Medical Officer	Option exerciseCode M · direct	49,307	$5.33	$263K@ $5.33	159,299	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.